UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 10.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 516,819 shares of the company’s stock after buying an additional 48,634 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in LifeStance Health Group were worth $3,618,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Townsquare Capital LLC bought a new position in LifeStance Health Group in the third quarter worth approximately $73,000. Park Edge Advisors LLC bought a new stake in LifeStance Health Group during the third quarter valued at about $73,000. CIBC Asset Management Inc purchased a new stake in LifeStance Health Group in the second quarter worth about $53,000. Algert Global LLC bought a new position in shares of LifeStance Health Group in the second quarter worth about $57,000. Finally, Victory Capital Management Inc. lifted its position in shares of LifeStance Health Group by 27.0% during the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock valued at $71,000 after buying an additional 3,063 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.
Insiders Place Their Bets
In related news, Director Robert Bessler sold 75,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the sale, the director now owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. The trade was a 5.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 6.60% of the company’s stock.
LifeStance Health Group Stock Up 0.4 %
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The firm had revenue of $312.70 million for the quarter, compared to the consensus estimate of $302.25 million. During the same quarter in the previous year, the firm earned ($0.17) earnings per share. The company’s quarterly revenue was up 18.9% compared to the same quarter last year. Research analysts predict that LifeStance Health Group, Inc. will post -0.2 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms have commented on LFST. Barclays raised their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. UBS Group reduced their price objective on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research note on Thursday, August 15th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Hold” and a consensus price target of $8.50.
Read Our Latest Report on LifeStance Health Group
LifeStance Health Group Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
- Five stocks we like better than LifeStance Health Group
- Buy P&G Now, Before It Sets A New All-Time High
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Consumer Staples Stocks, Explained
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- 3 Small Caps With Big Return Potential
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report).
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.